• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Crenezumab Antibody – Human Monoclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5819073

Crenezumab (MABT 5102A; RG 7412) is a fully humanized anti-Abeta monoclonal antibody that binds multiple forms of Abeta, such as soluble, oligomeric and fibrillar, for use in Alzheimer's disease research. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Crenezumab, Monoclonal Antibody
Full Product Name
Crenezumab
Clonality
Monoclonal
Host
Human
Species Reactivity
Abeta
Preparation and Storage
Powder: -20 degree C for 3 years | In solvent: -80 degree C for 1 year
Solubility
(< 1 mg/ml refers to the product slightly soluble or insoluble)
CAS Number
1095207-05-8

Other Notes

Small volumes of anti-Crenezumab antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Crenezumab purchase

MBS5819073 is an antibody targeting Crenezumab. Reactive in Abeta. Host: Human.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000